Antibody Therapies for Large B-Cell Lymphoma

Antibody Therapies for Large B-Cell Lymphoma

Mattia Novo,1 Elisa Santambrogio,2 Pio Manlio Mirko Frascione,3,4 Delia Rota-Scalabrini,1 Umberto Vitolo1 1Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy; 2Hematology Unit, Santa Croce e Carle Hospital, Cuneo, Italy; 3Medical Oncology, Candiolo Canc...

Full description

Bibliographic Details
Main Authors:	Novo M, Santambrogio E, Frascione PMM, Rota-Scalabrini D, Vitolo U
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	Biologics: Targets & Therapy
Subjects:	diffuse large b cell lymphoma immunotherapy target therapy monoclonal antibodies checkpoint inhibitors bispecific antibodies.
Online Access:	https://www.dovepress.com/antibody-therapies-for-large-b-cell-lymphoma-peer-reviewed-fulltext-article-BTT

Similar Items

New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
by: Mattia Schipani, et al.
Published: (2023-12-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
by: Suheil Albert Atallah-Yunes, et al.
Published: (2022-01-01)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
by: Sotirios G. Papageorgiou, et al.
Published: (2022-04-01)

Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
by: Patrick Willard, et al.
Published: (2021-01-01)

Bispecific antibodies and their use in applied research
by: Harshit Verma, et al.
Published: (2012-01-01)

Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
by: Alberto Mussetti, et al.
Published: (2022-08-01)

Novel biologic therapies in relapsed or refractory diffuse large B cell lymphoma: CAR-T is not the only answer.
by: Jérôme Paillassa, et al.
Published: (2022-01-01)

Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
by: Zhijuan Lin, et al.
Published: (2023-04-01)

Can bispecific antibodies change the paradigm and goals of therapy for patients with relapsed non-Hodgkin lymphomas?
by: Irina V. Poddubnaya
Published: (2023-12-01)

Development of combinatorial antibody therapies for diffuse large B cell lymphoma
by: Eric S. Geanes, et al.
Published: (2022-10-01)

Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5
by: Frank Breitling, et al.
Published: (2013-05-01)

Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma
by: Clifford M. Csizmar, et al.
Published: (2021-03-01)

Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)

Editorial: Therapeutic antibody domains against cancer
by: Qi Zhao, et al.
Published: (2023-08-01)

The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma
by: Meera Mohan, et al.
Published: (2021-09-01)

Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development
by: Ahmad Iftikhar, et al.
Published: (2019-05-01)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
by: Mattia D’Agostino, et al.
Published: (2020-11-01)

Rituximab for primary cutaneous large B-cell non-Hodgkin's lymphoma of the scalp
by: Čolović Nataša, et al.
Published: (2008-01-01)

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions
by: David A. Russler-Germain, et al.
Published: (2023-07-01)

Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future
by: Ling Wang, et al.
Published: (2022-09-01)

Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies
by: Reyad Dada
Published: (2023-07-01)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by: Vitaly Chasov, et al.
Published: (2024-02-01)

Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era
by: Eva González Barca
Published: (2022-07-01)

Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
by: Christoph Renner, et al.
Published: (2018-06-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
by: Nicholas Gravbrot, et al.
Published: (2019-10-01)

Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma
by: Giulio Cassanello, et al.
Published: (2024-12-01)

Emerging Trends in Immunotherapy for Cancer
by: Alok K. Mishra, et al.
Published: (2022-09-01)

Advances in the diagnosis and control of lymphomas
by: Myrna Candelaria
Published: (2016-03-01)

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
by: Mehdi Mohammadi, et al.
Published: (2021-02-01)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
by: Mariam Elshiaty, et al.
Published: (2021-05-01)

CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure
by: Ana Carolina Caballero, et al.
Published: (2022-07-01)

The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
by: Rita Tavarozzi, et al.
Published: (2022-02-01)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
by: Rebecca Adams, et al.
Published: (2022-12-01)

Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
by: Waqqas Tai, et al.
Published: (2022-03-01)

Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice
by: Nanna Skeltved, et al.
Published: (2023-04-01)

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
by: Robert Pytlik, et al.
Published: (2020-11-01)

T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
by: Ondine Messéant, et al.
Published: (2021-08-01)

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)

Bispecific Antibodies Progression in Malignant Melanoma
by: Juan Tang, et al.
Published: (2022-03-01)